SIRENADE Pharmaceuticals AG Announces Breakthrough In The Development Of Tau-Directed Therapeutics To Treat Alzheimer's Disease
10/19/2005 5:11:48 PM
More...
|
SIRENADE Pharmaceuticals AG Appoints Lynn Butler As New CEO
10/19/2005 5:11:23 PM
More...
|
NADAG AG And SiREEN AG Announce Merger To Form SIRENADE Pharmaceuticals AG And Launch EUR20 Million Financing Round
10/19/2005 5:09:40 PM
More...
|